Dianthus Therapeutics | MGTA - Les Charges D'Exploitation

Prix De L'Action
85.49
Variation Quotidienne
-0.25 -0.29%
Mensuellement
-10.72%
Annuel
355.95%
Q2 Prévisions
84.92




Les Charges D'Exploitation Changement Date
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 1.19M 148K 2025-09
Avita Medical AUD 28.02M 1.55M 2025-12
Celltrion KRW 140.68B 584.31B 2025-12
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Divis Laboratories Ltd INR 18.32B 1.08B 2025-12
IQVIA Holdings USD 6.22B 4.53B 2026-03
Kangmei Pharma CNY 1.39B 144.29M 2025-09
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Moderna USD 1.78B 242M 2026-03
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Organigram Holdings CAD 83.66M 24.44M 2025-12
Organon & Co USD 903M 387M 2026-03
Ovoca Bio EUR 1.16M 4.48M 2025-06
Pharma Mar EUR 42.28M 4.59M 2026-03
Qiagen NV USD 418.54M 23.25M 2025-12
Revvity USD 628.34M 2.12M 2026-03
Sartorius EUR 738.4M 22.4M 2026-03
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Tectonic Therapeutic USD 21.52M 374K 2025-12
Tilray USD 237.52M 17.34M 2025-09
Viatris USD 3.54B 323.9M 2026-03
Xeris Pharmaceuticals USD 69.03M 1.38M 2025-12
Zealand Pharma A/S 775.97M 265.08M 2025-12
Zz Pientze Pharmaceu CNY 1.88B 326.34M 2026-03